tiprankstipranks
Trending News
More News >
Minerva Neurosciences (NERV)
NASDAQ:NERV

Compare Minerva Neurosciences (NERV) vs. Competitors

Compare
612 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Minerva Neurosciences
$4.93
$202.52M
-2.66
118.63%
0 Buy
2 Hold
0 Sell
Hold
Bioline RX Ltd Sponsored ADR
$3.04
$13.55M
-2.23
-10.32%
1 Buy
0 Hold
0 Sell
Moderate Buy
Pulmatrix
$2.35
$9.46M
-1.53
-65.33%
Chemomab Therapeutics
$1.62
$10.28M
-0.87
-80.99%
2 Buy
0 Hold
0 Sell
Moderate Buy
Abpro Holdings
$1.86
$5.22M
-0.15
-93.40%
0 Buy
0 Hold
0 Sell
Hold
Aspire Biopharma Holdings
$1.63
$5.88M
-0.02
-99.61%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NERV
Minerva Neurosciences
4.93
2.55
107.14%
BLRX
Bioline RX Ltd Sponsored ADR
3.04
-0.59
-16.25%
PULM
Pulmatrix
2.60
-4.79
-64.82%
CMMB
Chemomab Therapeutics
1.62
-6.70
-80.53%
ABP
Abpro Holdings
1.90
-27.80
-93.60%
ASBP
Aspire Biopharma Holdings
1.63
-504.37
-99.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts